-
CheckOrphan NewsFlash, March 2,…
3/02/2010
CheckOrphan NewsFlash for Tuesday, March 2, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash January 15,…
1/15/2010
CheckOrphan NewsFlash for Friday, January 15, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash January 11,…
1/11/2010
CheckOrphan NewsFlash for Monday, January 11, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Interdisciplinary Training…
15–16 March, 2010
The goal of this meeting is to mentor the career development of a “…
-
ICORD 2010: Sixth International…
18–20 March, 2010
The VI International Conference on Rare Diseases and Orphan Drugs (ICORD…
-
Improving Musculoskeletal Outcomes…
7–9 April, 2010
The goals of this workshop are to (1) assess the state of knowledge…
-
Third NIH Workshop on Gaucher…
8–9 April, 2010
Workshop goals are to (1) determine the appropriate human, animal, or cell…
Events
-
Mesothelioma That Killed Merlin Olsen Tough to Beat
Friday, March 12, 2010
SALT LAKE CITY -- Merlin Olsen passed away Wednesday from mesothelioma, but a doctor has given tips on how to fight the lung disease that took the U.S.U. football star's lifeWhen a tumor invades, the lungs become unable to absorb fluid in the chest cavity. The fluid build-up causes pressure in th
-
Roche Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Friday, March 12, 2010
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the topline results of a phase III trial led by the US Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute investigating the use of Avastin (bevacizumab) in combination with docetaxel chemotherapy and prednisone in T
-
Ulcerative Colitis Product Granted Reimbursement in Sweden
Friday, March 12, 2010
Ulcerative colitis (UC) is a form of inflammatory bowel disease characterized by a chronic inflammation often with ulcers in the large intestineThe symptoms of UC can differ between patients in terms of frequency and severity. The amount of the large intestine affected by UC also varies between pa
-
Holyhead's Women Footballers Take on Challenge for Amlwch Sisters
Friday, March 12, 2010
A charity football match is set to take place later this month to help raise £400 to £500 to buy new life saving equipment for two young sisters in Amlwch who suffer from a life threatening conditionCybi FC women’s team, set up by former Holyhead and Anglesey Mail reporter Rachel
-
Barrier in Mosquito Midgut Protects Invading Pathogens
Friday, March 12, 2010
What: Scientists studying the Anopheles gambiae mosquito – the main vector of malaria – have found that when the mosquito takes a blood meal, that act triggers two enzymes to form a network of crisscrossing proteins around the ingested bloodThe formation of this protein barrier, the re
-
PA's Kilimanjaro Climb Raises Awareness, $110K
Friday, March 12, 2010
Climbing Mount Kilimanjaro, at more than 19,300 feet, is so difficult that only 40% of climbers attempting to summit the mountain make it, says Jessica Lazar, MPA, PA-CThe primary reason? Altitude sicknessLazar would know. Not only has she has specialized in treating patients with pulmonary hyper
-
Molecular Basis for Pseudomonas Aeruginosa Persistent Infections in CF Patients
Friday, March 12, 2010
New research reveals Small Colony Variants (SCVs) of P. aeruginosa to be a hallmark of chronic infection in cystic fibrosis (CF) patients. Results, published March 12th in the open-access journal PLoS Pathogens, suggest that SCV-mediated persistence might be a good target for antimicrobial Cystic
-
Research Sheds Light on the Inner Workings of the Inflammatory Response to Leishmaniasis
Friday, March 12, 2010
The secret world of inflammation is slowly being revealed by the application of advanced techniques in microscopy, as shown in a study published March 12 in the open-access journal PLoS PathogensResearchers at the Hull York Medical School and the University of York used 2-photon microscopy to iden
-
Staying Strong: Bone Marrow Match Sought for Dayton Father
Friday, March 12, 2010
Vinod Challagundla learned in December he had a potentially fatal disease, but he didn't want to alarm his mother or pregnant wife. So he kept it to himselfFor three months, the state software consultant quietly searched the Internet for information and snuck away to doctor's appointments for bloo
-
Stimuvax Will Become Decision Resources' Proprietary Clinical Gold Standard for the Treatment of Locally Advanced Non-Small-Cell Lung Cancer
Friday, March 12, 2010
WALTHAM, Mass. -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Merck KGaA/Oncothyreon's Stimuvax vaccine earns Decision Resources' proprietary clinical gold standard status in 2013 and 2018 for the treatment of Avai
